conv.

← The whole story
Business
Eli Lilly captures 70% of new Medicare weight-loss drug patients

Lilly's market dominance reflects strategic positioning within Medicare program

2 Sep 22 9:00 AM · 4d ago · 1 article · 1 source · development 2 of 2

Analysis shows Lilly's 70% capture of new Medicare patients extends its recent market gains. Foundayo, the oral pill, attracts one-third of new oral drug patients seeking convenience and smaller weight loss, while Zepbound dominates for patients with higher complications. Lilly's position has widened from roughly 61% of the combined obesity and diabetes market in Q2 compared with 39% for Novo.

Lilly's market dominance reflects strategic positioning within Medicare program
Quartz

“The pill is better suited for patients who prefer a convenient treatment format and need to lose a smaller amount of weight.”

Dave Ricks

Dave Ricks Eli Lilly CEOEli LillyEli Lilly Pharmaceutical manufacturerCenters for Medicare and Medicaid Services Program administrator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 3 pieces in two hours at Sep 21, 12 PM; 5 pieces over 5 days (4 articles · 1 post) Sep 21, 12 PM — 3 pieces · 2 articles · 1 post — Google News 1, Mastodon 1, Newswires 1Sep 21, 2 PM — quietSep 21, 4 PM — quietSep 21, 6 PM — quietSep 21, 8 PM — quietSep 21, 10 PM — quietSep 22, 12 AM — quietSep 22, 2 AM — quietSep 22, 4 AM — quietSep 22, 6 AM — quietSep 22, 8 AM — 1 piece · 1 article — Newswires 1Sep 22, 10 AM — quietSep 22, 12 PM — quietSep 22, 2 PM — 1 piece · 1 article — Google News 1Sep 22, 4 PM — quietSep 22, 6 PM — quietSep 22, 8 PM — quietSep 22, 10 PM — quietSep 23, 12 AM — quietSep 23, 2 AM — quietSep 23, 4 AM — quietSep 23, 6 AM — quietSep 23, 8 AM — quietSep 23, 10 AM — quietSep 23, 12 PM — quietSep 23, 2 PM — quietSep 23, 4 PM — quietSep 23, 6 PM — quietSep 23, 8 PM — quietSep 23, 10 PM — quietSep 24, 12 AM — quietSep 24, 2 AM — quietSep 24, 4 AM — quietSep 24, 6 AM — quietSep 24, 8 AM — quietSep 24, 10 AM — quietSep 24, 12 PM — quietSep 24, 2 PM — quietSep 24, 4 PM — quietSep 24, 6 PM — quietSep 24, 8 PM — quietSep 24, 10 PM — quietYesterday, 12 AM — quietYesterday, 2 AM — quietYesterday, 4 AM — quietYesterday, 6 AM — quietYesterday, 8 AM — quietYesterday, 10 AM — quietYesterday, 12 PM — quietYesterday, 2 PM — quietYesterday, 4 PM — quietYesterday, 6 PM — quietYesterday, 8 PM — quietYesterday, 10 PM — quietToday, 12 AM — quietToday, 2 AM — quietToday, 4 AM — quietToday, 6 AM — quietToday, 8 AM — quietToday, 10 AM — quietToday, 12 PM — quiet 12
1Ricks reports 700,000 seniors on…2Lilly's market dominance reflects…
Sep 22Sep 23Sep 24yesterdaynow · 1:40 PM ET

What was reported 1 claim about this development

  1. 1 outlet Eli Lilly is capturing 70% of new Medicare patients on weight-loss drugs, CEO says

    first by Quartz, 4d ago

All 2 developments of Eli Lilly captures 70% of new Medicare weight-loss drug… →

NewswiresMastodonGoogle News